Development and characterization of an organic solvent free, proliposomal formulation of Busulfan using quality by design approach.
Sign Up to like & getrecommendations! Published in 2018 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2017.11.007
Abstract: Parenteral administration of Busulfan (BU) conquers the bioavailability and biovariability related issues of oral BU by maintaining the plasma drug concentration in therapeutic range with minimal fluctuations thereby significantly reducing the side effects. Busulfex® is… read more here.
Keywords: busulfan; design; proliposomal formulation; formulation ... See more keywords